Skip to main content
HairCited

B12 Vitamini için Telogen Effluvium

F

13 çalışmaya, toplam 8,121 katılımcıyla dayanmaktadır. Sonuçlar çalışmalar arasında karışıktır.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Db12\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

Sonuç

Research does not clearly support vitamin B12 supplementation for telogen effluvium — while low B12 is sometimes found in hair loss patients, there is no strong evidence that supplementation helps recovery.

  • Mixed results across 13 observational studies
  • Some post-COVID hair loss studies measured B12 levels without finding consistent patterns
  • No RCTs testing B12 supplementation for telogen effluvium
  • Only worth supplementing if a blood test confirms a B12 deficiency

Key Study Findings

retrospective observational n=113
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.
Dose: None vs: Placebo Etki: None None
Retrospective cohort n=2851
Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.
Dose: None vs: Placebo Etki: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05
retrospective cross-sectional study n=467
Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
Dose: not applicable vs: Placebo Etki: None 0.001

Key Statistics

13

Çalışmalar

8121

Katılımcılar

Mixed

F

Derece

Referenced Papers

Acta dermatovenerologica Croatica … 2016 6 atıf
Dermatologic clinics 1993 38 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
2.4 mcg/day
deficiency:
1,000-2,000 mcg/day

Üst sınır: No established UL

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Neutral 113
None -- Neutral 2851
None -- Mixed 108
not applicable -- Mixed 180
None -- Positive 973
not applicable -- Mixed 467
standard replacement doses -- Neutral 3028
None -- Neutral 100

En iyi alım zamanı: With meals; sublingual form can be taken any time

Safety & Side Effects

Bildirilen Yan Etkiler

  • Generally well tolerated even at high doses
  • Rare allergic reactions (itching, swelling)
  • Mild diarrhea or nausea at very high doses

Bilinen Etkileşimler

  • Metformin (reduces B12 absorption by 10-30%)
  • Proton pump inhibitors and H2 blockers (reduce B12 absorption)
  • Colchicine (may reduce B12 absorption)

Tolere edilebilir üst alım: No established UL

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does B12 Vitamini help with Telogen Effluvium?
Based on 13 studies with 8,121 participants, there is insufficient evidence at this time that B12 Vitamini may support Telogen Effluvium management. Our evidence grade is F (Evidence Against).
How much B12 Vitamini should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 2.4 mcg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of B12 Vitamini?
Reported side effects may include Generally well tolerated even at high doses, Rare allergic reactions (itching, swelling), Mild diarrhea or nausea at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for B12 Vitamini and Telogen Effluvium?
We rate the evidence as Grade F (Evidence Against). This rating is based on 13 peer-reviewed studies with 8,121 total participants. The overall direction of effect is mixed.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.